PlainRecalls
FDA Drug Low Class III Ongoing

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13

Reported: June 21, 2023 Initiated: June 13, 2023 #D-0875-2023

Product Description

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Details

Recalling Firm
AVKARE LLC
Units Affected
592 cartons
Distribution
Nationwide in the USA.
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13. Recalled by AVKARE LLC. Units affected: 592 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 21, 2023. Severity: Low. Recall number: D-0875-2023.